http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004506696-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate | 2001-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2004-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2004506696-A |
| titleOfInvention | How to treat a demyelinating disease |
| abstract | The present invention provides a method for treating the severity of a paralytic disease in a subject by administering to a subject having a paralytic disease an effective amount of a neutralizing agent specific to 10 kDa interferon-inducible protein (IP-10). And a method for reversing its neurological effects. The method of the present invention comprises administering to a subject having a paralytic disease a therapeutically effective amount of a 10-kDa interferon-inducible protein (IP-10) -specific neutralizing agent, whereby the subject suffering from the paralytic disorder is administered. Promotes remyelination of denervated nerve fibers in the body and prevents further denervation of nerve fibers. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006008705-A |
| priorityDate | 2000-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 187.